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Abstract An actinobacteria strain PAL114, isolated from a
Saharan soil in Algeria, produces bioactive compounds.
Morphological and chemical studies indicated that this strain
belongs to the genus Streptomyces. Analysis of the 16S rRNA
gene sequence showed a similarity level of 99.8 % with
S. griseoflavus LMG 19344T, the most closely related species.
Two bioactive compounds, named P44 and P40, were extract-
ed by dichloromethane from the cell-free supernatant broth
and were purified by HPLC. Minimum inhibitory concentra-
tions (MIC) of the compounds were determined against path-
ogenic and toxigenic microorganisms, most of which are
multiresistant to antibiotics. The P40 fraction showed a strong
activity especially against Candida albicans, Bacillus subtilis,
and Staphylococcus aureus and has lower MIC values than
those of P44 against most microorganisms tested. Chemical
structures of compounds were determined based on spectro-
scopic and spectrometric analyses (UV-visible, mass, 1H, and
13C NMR spectra). The compounds P44 and P40 were iden-
tified as vineomycin A1 and chaetoglobosin A, respectively.
Vineomycin A1 is known to be produced by some
Streptomyces species. However, chaetoglobosin A is known
to be produced only by fungi belonging to the genera
Chaetomium, Penicillium, and Calonectria. This is the first
time that chaetoglobosin A, known for its antimicrobial, anti-
cancer, and cytotoxic effects, is reported in prokaryotes.
Keywords Streptomyces . Vineomycin A1 . Chaetoglobosin
A . Chemical structure . Bioactive compounds
Introduction
Actinobacteria are Gram-positive bacteria with a percentage
of guanine-cytosine higher than 55 %, and most of them
produce mycelia. They are particularly interesting for their
high capacity to produce secondary metabolites with diverse
chemical structures (Watve et al. 2001). Among these com-
pounds, there are, for example, antivirals, antiparasitics,
immunostimulants, and immunosuppressants. However,
actinobacteria are especially known for the production of
antibiotics (Takahashi and Omura 2003; Solanki et al. 2008).
Indeed, over 45 % of bioactive molecules of microbial origin
are produced by actinobacteria (Solecka et al. 2012). Among
these molecules, about 80 % are produced by species of the
genus Streptomyces, the most common genus in the environ-
ment (Demain 2006; Jose et al. 2011). The antibiotics secreted
by this genus may have antibacterial or antifungal activities, or
cytostatic and antitumor properties, such as adriamycin and
anthramycin (Butler 2004). Many of these molecules have
found an important therapeutic application (Jose and
Jebakumar 2013).
Our previous works showed the richness of Algeria
Saharan soil with actinobacteria producers of bioactive com-
pounds (Sabaou et al. 1998). Therefore, many strains proved
to be new species producing new bioactive molecules (Lamari
et al. 2002a, b; Zitouni et al. 2004a, b, 2005; Badji et al. 2006,
2007; Merrouche et al. 2010; Boubetra et al. 2012).
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A previous work performed on a Saharan actinobacteria
strain named PAL114 revealed the production of two bioac-
tive molecules identified as saquayamycins A and C, known
as anticancer agents (Aouiche et al. 2014). In the present
article, which is the continuation of a previously published
work, the taxonomy of actinomycete strain and the produc-
tion, purification, structure elucidation, and bioactivity of two
other bioactive molecules produced by the same strain are
described.
Materials and methods
Identification of actinobacteria strain PAL114
The actinobacteria strain PAL114 was isolated from a Saharan
soil collected fromGhardaïa province, south Algeria (Aouiche
et al. 2014).
The morphological and cultural characteristics were ob-
served by naked-eye examination of 14 day-old cultures
grown on various ISP (International Streptomyces Project)
media: yeast extract–malt extract agar (ISP2), oatmeal agar
(ISP3), inorganic salts–starch agar (ISP4), and glycerol–as-
paragine agar (ISP5) (Shirling and Gottlieb 1966), and also on
Bennett medium (Waksman 1961). The micromorphology
and sporulation were observed by light microscopy.
For chemotaxonomic analyses, biomass was obtained from
a culture grown in shaken ISP2medium (Shirling and Gottlieb
1966) and incubated at 30 °C for 4 days. Analysis of
diaminopimelic acid isomers and whole-cell sugar pattern
were carried out using the method of Becker et al. (1964)
and Lechevalier and Lechevalier (1970). Phospholipids were
analysed according to the procedures developed by Minnikin
et al. (1977).
For the physiological study, 18 tests were used (Locci
1989), including the production of melanoid pigments on
ISP6 and ISP7 media, the assimilation of nine carbohydrates
as sole carbon source, the degradation of xanthine, the pro-
duction of nitrate reductase, the sensitivities to sodium chlo-
ride (7 % w/v), sodium azide (0.01 % w/v), phenol (0.1 %
w/v), and penicillin (10 UI), and the growth at 45 °C.
For molecular analysis, DNAwas extracted using the pro-
cedure recommended by Liu et al. (2000). PCR amplification
of the 16S rRNA gene sequence of strain PAL114 was per-
formed using two primers: 27f (5′-AGAGTTTGATCCTGGC
TCAG-3′) and 1492r (5′- GGTTACCTTGTTACGACTT-3′).
The 16S rRNA gene sequence was amplified by PCR using an
Invitrogen Kit and sequenced. The sequences obtained were
compared with sequences present in the public sequence
databases and with the EzTaxon-e server (Kim et al. 2012).
Phylogenetic analyses were conducted using MEGA ver-
sion 5.0 (Tamura et al. 2011). The 16S rRNA gene sequence
of strain PAL114 was aligned using the CLUSTAL W
program (Thompson et al. 1994) against corresponding nu-
cleotide sequences of representatives of the Streptomyces
genus retrieved from GenBank. Evolutionary distance matri-
ces were generated as described by Jukes and Cantor (1969)
and a phylogenetic tree was established using the neighbor-
joining method of Saitou and Nei (1987). The topology of the
tree was evaluated by bootstrap analysis (Felsenstein 1985)
using 1,000 resamplings.
Production and purification of antimicrobial compounds
Production of bioactive compounds were conducted in ISP2
broth (malt extract 10 g, yeast extract 4 g, glucose 4 g, distilled
water 1,000 mL, pH 7.2). A seed culture was prepared with
the same medium and used to inoculate 80 Erlenmeyer flasks
of 500 mL, each containing 100 mL of medium. The cultures
were incubated on a rotary shaker (250 rpm) at 30 °C. The
extraction of active compounds was performed on the fifth
day, previously determined as being the day of optimum
production. The ISP2 culture broth was centrifuged to elimi-
nate cells. The cell-free supernatant was extracted with an
equal volume of dichloromethane. The organic extract was
concentrated to dryness by rotary evaporator under a vacuum
at a temperature lower than 40 °C. The resulting dry extract
was recuperated in 10 mL of methanol and bioassayed against
Candida albicans M3, Aspergillus carbonarius M333, and
Bacillus subtilis ATCC 6633 by paper disc diffusion method.
Preparative chromatography with silica gel plates (Merck
Art. 5735, Kiesselgel 60HF 254–366; 20×20 cm) was
employed for the partial purification of bioactive product.
TLC plates were developed in the solvent system ethyl ace-
tate–methanol (100:15 v/v). The developed plates were air
dried overnight to remove all traces of solvents. The separated
compounds were visualized under UVat 254 nm (absorbance)
and 365 nm (fluorescence), and the active spot was detected
by bioautography (Betina 1973). The retention factor (Rf) of
the active spot was measured.
The final purification of bioactive compound was carried
out by Waters reverse phase HPLC using an XBridge C18
(5 μm) column (200×10 mm, Waters) with a continuous
linear gradient solvent system from 20 to 100 % meth-
anol in water, a flow rate of 2 mL/min, and UV detec-
tion at 220 and 254 nm. All peak fractions were col-
lected and tested against Candida albicans M3,
Aspergillus carbonarius M333, and Bacillus subtilis
ATCC 6633. The active fractions were re-injected into
the HPLC system under the same conditions as previ-
ously, until their final purification.
Identification of bioactive compounds
These analyses were made with the pure bioactive com-
pounds. The UV spectra were determined with a
Shimadzu UV1605 spectrophotometer. The mass spectra
were recorded on an LCQ ion-trap mass spectrometer
(Finnigan MAT, San Jose, CA, USA) with nanospray
ion electro-spray ionization (ESI) source (positive and
negative ion modes). 1H and 13C NMR spectroscopy
were used for the characterization of two bioactive
molecules. NMR sample was prepared by dissolving
3 mg of each compound in 600 μL of CD3OD. All
spectra were recorded on a Bruker Avance 500 spec-
trometer equipped with a cryoprobe. All chemical shifts
Table 1 Resistance pattern of target fungi and bacteria to antibiotics
Target microorganisms Resistant to: Sensitivity to:
Yeasts and filamentous fungi
Saccharomyces cerevisiae ATCC 4226 N, I, Th, T C, A
Candida albicansM1, M3, IPA200 and IPA988 N, I, Th, T, C A
Penicillium glabrum PG1 C N, I, Th, T, A
Aspergillus carbonarius M333 C, N I, Th, T, A
A. flavus AF3 C N, I, Th, T, A
A. ochraceus AO1 C, N, T I, Th, A
Fusarium culmorum FC200 C, N, T, I, A Th
Bacteria
Bacillus subtilis ATCC 6633 NEO CH, CAR, CHL, ERY, K, SPI, SSS, VAN
Staphylococcus aureus S1 CAR, K, NEO, OLE, SPI, VAN CH
Escherichia coli E195 AMC, AMX, CAZ, CF, CTX, CXM, FOX, TCC, TIC CH, CXC
A, amphotericin B; C, cycloheximide; I, itraconazole; N, nystatin; T, thioconazole; Th, terbinafine; AMX, amoxicillin; AMC, amoxicillin + clavulanic
acid; CH, chloramphenicol; CAR, carbenicillin; CAZ, ceftazidime; CF, cefalotin; CTX, cefotaxime; CXC, cefotaxime + clavulanic acid; CXM,
cefuroxime; ERY, erythromycin; FOX, cefoxitin; K, kanamycin; NEO, neomycin; OLE, oleandomycin; SPI, spiramycin; SSS, sulfamide; TCC,
ticarcillin + clavulanic acid; TIC, ticarcillin; VAN, vancomycin
0.001
Streptomyces althioticus NRRL B 3981T (AY999791)
Streptomyces labedae NBRC 15864T (AB184704)
Streptomyces erythrogriseus LMG 19406T (AJ781328)
Streptomyces griseoincarnatus LMG 19316T (AJ781321)
Streptomyces variabilis NBRC 12825T (AB184884)
Streptomyces griseorubens NBRC 12780T (AB184139)
Strain PAL114
Streptomyces griseoflavus LMG 19344T (AJ781322)
Streptomyces malachitofuscus NBRC 13059T (AB184282)
Streptomyces tendae ATCC 19812T (D63873)
Streptomyces flaveolus NBRC 3715T (AB184786)
Streptomyces paradoxus NBRC 14887T (AB184628)
Streptomyces azureus NBRC 12744T (AB184837)
Streptomyces viridochromogenes NBRC 3113T (AB184728)
Streptomyces ambofaciens ATCC 23877T (M27245)
70
75
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99
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Fig. 1 Neighbor joining tree based on 16S rRNA gene sequences show
ing the relation between strain PAL114 and type species of the genus
Streptomyces. The numbers at the nodes indicate the levels of bootstrap
support (≥50%) based on neighbour joining analyses of 1,000 resampled
data sets. Bar, 0.001 nt substitution per nt position
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for 1H and 13C are relative to TMS using 1H (residual)
or 13C chemical shifts of the solvent as a secondary
standard. The temperature was set at 298 K. All the 1H
and 13C signals were assigned on the basis of chemical
shifts, spin-spin coupling constants, splitting patterns
and signal intensities, and by using 1H-1H COSY45,
1H-1H TOCSY, 1H-13C HSQC, and 1H-13C HMBC ex-
periments. Gradient-enhanced 1H COSY45 was realised
including 36 scans for per increment. The mixing time
for TOCSY was 60 ms and 96 scans per increment
were accumulated. 1H-13C correlation spectra using a
gradient-enhanced HSQC sequence (delay was optimised
for 1JCH of 145 Hz) was obtained with 200 scans per
increment. Gradient-enhanced HMBC experiment was
performed allowing 62.5 ms for long-range coupling
evolution (340 scans were accumulated). Typically,
2,048 t2 data points were collected for 256 t1
increments.
Determination of minimum inhibitory concentrations
Minimum inhibitory concentrations (MIC) of pure bio-
active molecules were carried out using conventional
agar dilution (Oki et al. 1990). Thirteen target micro-
organisms, the majority of which are pathogenic or
toxigenic to humans and multiresistant to antibiotics
(Table 1), were used. Three bacteria (Bacillus subtilis
ATCC 6633 , S taphy lococcus aureus S1 , and
Escherichia coli E195), five filamentous fungi
(Aspergillus carbonarius M333, A. flavus AF3,
A. ochraceus AO1, Fusarium culmorum FC200, and
Penicillium glabrum PG1), and five yeasts (Candida
a lb icans M1, M3, IPA200, and IPA988, and
Saccharomyces cerevisiae ATCC 4226) were inoculated
onto Mueller Hinton medium for bacteria and
Sabouraud medium for fungi, containing different con-
centrations of active compounds (1, 2, 5, 10, 20, 30,
50, 75, and 100 μg/mL). After a growth period of 24–
48 h at 37 °C for bacteria and 48–72 h at 28 °C for
fungi, the plates were examined for growth and the
lowest bioactive compound concentration that inhibited
the growth of each organism was determined. Mueller
Hinton and Sabouraud media, without active compound
and inoculated with target organisms, were used as
control treatments.
Table 2 1H and 13C NMR data assignments of P44 compound in
CD3OD at 298K. See Fig. 2b for numbering of hydrogen and carbon
atoms
1H and 13C number 1H chemical shift, ppm 13C chemical shift, ppm
1 1.33 14.04
2 4.61 70.21
3 197.28
4 7.04 144.19
5 6.08 126.13
6 5.34 95.13
7 1.25 16.10
8 4.24 66.33
9 3.71 76.40
10 1.51 1.69 24.40
11 1.97 23.93
12 5.25 92.10
13 1.39 24.90
14 81.95
15 1.99 2.32 42.61
16 79.80
17 79.50
18 205.28
19 2.73 2.93 50.18
20 6.90 116.65
21 6.41 145.40
22 139.03
23 138.50
24 182.30
25 137.68
26 130.97
27 182.30
28 157.40
29 114.00
30 7.89 132.84
31 7.62 118.63
32 1.38 17.39
33 3.56 75.18
34 3.15 86.45
35 3.82 71.13
36 1.41 2.49 39.28
37 4.92 70.98
38 1.23 15.72
39 4.37 67.34
40 3.76 76.28
41 1.99 2.11 23.93
42 1.51 1.69 24.40
43 5.01 98.92
44 1.33 14.04
45 4.61 70.21
46 197.34
47 7.02 144.09
Table 2 (continued)
1H and 13C number 1H chemical shift, ppm 13C chemical shift, ppm
48 6.09 126.18
49 5.35 95.13
Results and discussion
Identification of strain PAL114
The strain PAL114 showed good growth on ISP2, ISP3, ISP4,
ISP5, and Bennett media. The aerial and substrate mycelia
were light to medium grey and light brown, respectively. A
diffusible pigment with light brown color was produced on
ISP2, ISP3, and Bennett media. The strain PAL114 formed a
very well-developed aerial mycelium with long spiraled
chains containing between 10 and 50 spores per chain. The
spores were carried by sporophores and were oval and 1–1.5×
0.6–1 μm in size. The substrate mycelium was
nonfragmented.
The chemotaxonomic study of strain PAL114 showed the
presence of LL-diaminopimelic acid isomer and glycin in the
cell wall. The whole-cell hydrolysates contained non-
characteristic sugars (ribose, glucose, and galactose), typical
of cell wall type IC (Lechevalier and Lechevalier 1970). The
phospholipid profile contained phosphatidylethanolamine,
corresponding to phospholipid type PII (Lechevalier et al.
1977). Based on the morphological and chemical characteris-
tics, strain PAL114 was identified to the genus Streptomyces
(Holt et al. 1994).
The strain PAL114 used arabinose, fructose, inositol, man-
nitol, melibiose, rhamnose, and xylose as carbon source, but
not sucrose and raffinose. Xanthine was degraded and nitrate
reduced. The strain grew at 45 °C in the presence of penicillin
(10 UI), phenol (0.1 % w/v), sodium azide (0.01 % w/v), and
NaCl (7 % w/v). The melanoid pigments were not produced
on ISP6 and ISP7 media.
The alignment of the 16S rRNA gene sequence (1471
nucleotides) of strain PAL114 with those of Streptomyces
reference species available in the GenBank database, can be
seen in the neighbor-joining dendrogram (Fig. 1). The simi-
larity level was 99.8 % with S. griseoflavus LMG 19344T
Fig. 2 Structure of bioactive
compound P44 (a) and HMBC
and COSY correlations (b)
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(Holt et al. 1994), the most closely related species. The mor-
phological and physiological properties of strain PAL114 are
similar to those of the type strain of S. griseoflavus except for
the tests of nitrate reduction and growth at 45 °C.
Purification of bioactive compounds
The dichloromethane extract was chromatographed by TLC
and developed in an ethyl acetate–methanol system (100–15
v/v). After migration, we observed one active bioautographic
compound, which showed a strong activity against Candida
albicans M3 and Bacillus subtilis ATCC 6633. This com-
pound (Rf=0.9), was selected and analyzed by HPLC. Two
active fractions (P44 and P40) were purified with 80 % meth-
anol in water. The fraction P40 was eluted at a retention time
of 39.68 min and P44 at 44.08 min. A quantity of 5 mg was
obtained for each molecule from 8 L of culture filtrate.
Identification of bioactive compounds
The UV-VIS spectrum of the bioactive compound P44
showed maxima at 218, 318, and 438 nm.
The mass spectrum of the compound was obtained in
negative mode. It yielded a pseudo-molecular ion [M - H] =
933. Thus, the molecular weight of antimicrobial compound is
M=934.
The 1H and 13C chemical shifts of P44 compound are given
in Table 2 and structure in Fig. 2. The HSQC and HMBC
spectra show 49 carbon signals for P44 molecule. It was
possible to discern five ketone groups (δc 182.30 to 205.28),
four hydroxyl groups (δc 71.13 to 157.40), nine ether func-
tions (δc 67.34 to 95.13), 13 sp
2–hybridized carbons (δc from
114.00 to 144.09), and 13 sp3-hybridized carbons (δc 14.04 to
42.61) for the P44 molecule. The hydrogens of the hydroxyl
group are not observed due to rapid exchange with MeOD.
The 2D 1H-1H and 1H-13C experiments, and especially the
long range 1H-13C couplings observed in the HMBC spectrum
(see Fig. 2b), permitted us to established the connectivity
between all the groups of the molecule.
The structure of the P44 molecule was determined by
NMR and mass spectrometry to be vineomycin A1. It is an
antibiotic belonging to the aquayamycin group, class of
angucycline, family of anthracycline (Maskey et al. 2003). It
is known to be active against Gram-positive bacteria and
sarcoma-180 solid tumors in mice (Imamura et al. 1982;
Omura 2011). Also, vineomycin A1 is a suitable treatment
for hypertrophic scar tissue and keloid disease. It is known to
be a potent inhibitor of prolyl 4-hydroxylase, an essential
enzyme involved in the post translational modification of
collagen causing several diseases such as fibrosis, arterio-
sclerosis, and scleroderma (Cunliffe and Franklin 1986;
Chen 2007). Furthermore, cytostatic activity in vivo has been
reported for vineomycins (Rohr and Thiericke 1992).
Vineomycins are known to be produced by actinobacteria,
especially Streptomyces species such as S. matensis and
S. albogriseolus (Ono et al. 1974; Chen 2007; Omura 2011),
but have never been reported in S. griseoflavus, to which our
strain was closely related.
For the P40 compound, the UV-VIS spectrum showed
maxima at 220 and 276 nm.
The mass spectrum of the compound was obtained in
negative mode. It yielded a pseudo-molecular ion [M - H] =
527. Thus, the molecular weight of antimicrobial compound is
M=528. The 1H and 13C chemical shifts of the P40 compound
are given in Table 3 and structure in Fig. 3. The HSQC and
HMBC spectra show 32 carbon signals for P40. From
these data, it was possible to discern two ketone groups
Table 3 1H and 13C NMR data assignments of the P40 compound in
CD3OD at 298 K. See Fig. 3b for numbering of hydrogen and carbon
atoms
1H and 13C number 1H chemical shift, ppm 13C chemical shift, ppm
1 6.95 124.2
2 108.0
3 127.5
4 136.6
5 7.26 111.3
6 7.49 118.1
7 7.00 118.4
8 7.03 120.7
9 2.84 32.1
10 3.91 57.7
11 2.89 46.4
12 63.1
13 174.3
14 1.73 36.3
15 58.0
16 2.78 62.1
17 2.05 48.9
18 1.08 12.1
19 1.30 18.4
20 6.04 128.3
21 5.13 132.7
22 2.00 2.29 41.3
23 2.47 31.8
24 5.53 139.2
25 132.3
26 5.00 81.5
27 200.5
28 6.13 131.7
29 7.27 134.4
30 197.3
31 1.00 19.8
32 1 33 9.5
(δc 197.3 and 200.5), one amide group (δc 174.3), one
hydroxyl group (δc 81.5), one epoxy group (δc 58.0 and
62.1), 14 sp2–hybridized carbons (δc from 108.0 to
136.6), and 14 sp3-hybridized carbons (δc 12.1 to
81.5). The hydrogens of the hydroxyl group are not
observed due to rapid exchange with MeOD. The 2D
1H-1H and 1H-13C experiments, and especially the long
range 1H-13C couplings observed in the HMBC spec-
trum (see Fig. 3b), permitted us to establish the con-
nectivity between all the groups of the P40 molecule.
The structure of the P40 compound was determined by
NMR and mass spectrometry to be chaetoglobosin A. This
compound is known for its antibacterial, antifungal, phytotox-
ic (June et al. 1998; Larsen et al. 2005; Zhang et al. 2013),
anticancer, and cytotoxic effects towards mammal cells
(Fisvad et al. 2004; Fogle et al. 2008), and nematicidal effects
(Hu et al. 2012). It has also been reported that this compound
increases fibrinolytic activity in bovine animals (Shinohara
et al. 2000). This compound is a cytochalasin derivative
(Ohtsubo et al. 1978; June et al. 1998). Furthermore, it is
considered a mycotoxin, and it is known to be produced only
by fungi such as Chaetomium globosum (Hu et al. 2012),
Penicillium discolor, P. expansum, P. marinum (Fisvad et al.
A
B
Fig. 3 Structure of bioactive
compound P40 (a) and HMBC
and COSY correlations (b)
Table 4 Minimum inhibitory concentrations (MIC) of the bioactive
compounds P44 and P40 secreted by the strain PAL114 against several
fungi and bacteria
Target microorganism MIC (μg/mL) a
P40 P44
Saccharomyces cerevisiae ATCC 4226 50 50
Candida albicansM1 50 75
C. albicansM3 30 75
C. albicans IPA200 50 75
C. albicans IPA988 50 75
Aspergillus carbonarius M333 50 100
A. flavus AF3 75 100
A. ochraceus AO1 50 75
Fusarium culmorum FC200 75 100
Penicillium glabrum PG1 75 75
Bacillus subtilis ATCC 6633 20 50
Staphylococcus aureus S1 30 >100
Escherichia coli E195 >100 >100
a MIC values represent the average of two replicates
2004), andCalonectria morganii (VonWallbrunn et al. 2001).
It has never been described in prokaryotes. This is the first
time that this compound is reported in the genus Streptomyces,
belonging to the class ofActinobacteria. All experiments were
made three times at different cultivation times to confirm fully
the production of chaetoglobosin A by strain PAL114.
Minimum inhibitory concentrations
Minimum inhibitory concentrations (MIC) of bioactive mol-
ecules purified by HPLC are summarized in Table 4.
For vineomycin A1 (P44), MIC values were between 50
and 75 μg/mL for yeasts, and 75 and 100 μg/mL for filamen-
tous fungi. For bacteria, Bacillus subtilis ATCC 6633 was the
most sensitive (50 μg/mL). All other bacteria tested were
resistant.
For chaetoglobosin A (P40), MIC values were between 30
and 75 μg/mL for yeasts, 50 and 75 μg/mL for filamentous
fungi, and 20 and 30 μg/mL for Gram-positive bacteria. All
Gram-negative bacteria tested were resistant. The most sensi-
tive microorganisms were Bacillus subtilis ATCC 6633
(20 μg/mL), Staphylococcus aureus S1 (30 μg/mL), and
Candida albicans M3 (30 μg/mL).
In conclusion, the strain PAL114, closely related to
S. griseoflavus, showed an antibacterial and antifungal activity
against pathogenic and toxigenic microorganisms, most of
which are resistant to several antibiotics. The bioactive com-
pounds produced by the strain proved to be the vineomycin
A1 and chaetoglobosin A.
Vineomycin A1 belongs to the same group, class, and
family as saquayamycins (Aouiche et al. 2014); it differs from
these compounds only by the presence of a saccharide deriv-
ative bonded to the carbon 40. Chaetoglobosin A is known to
be produced only by a small number of fungal species. This is
the first time that chaetoglobosin A, which, in addition to its
antimicrobial activity, is also considered a mycotoxin in the
scientific literature, is produced by prokaryotes such as
Actinobacteria.
Moreover, strain PAL114 represents a sample which con-
firms the potential of actinobacteria to produce a large variety
of bioactive molecules.
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